Human gnathostomiasis: A review on the biology of the parasite with special reference on the current therapeutic management
- PMID: 37719690
- PMCID: PMC10502356
- DOI: 10.1016/j.fawpar.2023.e00207
Human gnathostomiasis: A review on the biology of the parasite with special reference on the current therapeutic management
Abstract
Gnathostoma is a parasitic nematode that can infect a wide range of animal species, but human populations have become accidental hosts because of their habit of eating raw or undercooked meat from a wide variety of intermediate hosts. While gnathostomiasis is considered an endemic disease, cases of human gnathostomiasis have been increasing over time, most notably in nonendemic areas. There are several complexities to this parasitic disease, and this review provides an update on human gnathostomiasis, including the life cycle, diagnosis, treatment, and treatment strategies used to combat drug resistance. Even now, a definitive diagnosis of gnathostomiasis is still challenging because it is difficult to isolate larvae for parasitological confirmation. Another reason is the varying clinical symptoms recorded in reported cases. Clinical cases can be confirmed by immunodiagnosis. For Gnathosotoma spinigerum, the detection of IgG against a specific antigenic band with a molecular weight of 24 kDa from G. spinigerum advanced third-stage larvae (aL3), while for other species of Gnathostoma including G. binucleatum, the 33-kDa antigen protein is being used. This review also discusses cases of recurrence of gnathostomiasis and resistance mechanisms to two effective chemotherapeutics (albendazole and ivermectin) used against gnathostomiasis. This is significant, especially when planning strategies to combat anthelmintic resistance. Lastly, while no new chemotherapeutics against gnathostomiasis have been made available, we describe the management of recurrent gnathostomiasis using albendazole and ivermectin combinations or extensions of drug treatment plans.
Keywords: Anthelminthic resistance; Drug combination; Gnathostomiasis.
© 2023 The Authors. Published by Elsevier Inc. on behalf of International Association of Food and Waterborne Parasitology.
Conflict of interest statement
The authors hereby declare no conflict of interest.
Figures
Similar articles
-
Increasing Risk Factors for Imported and Domestic Gnathostomiasis in the United States.J La State Med Soc. 2015 Sep-Oct;167(5):215-9. Epub 2015 Oct 15. J La State Med Soc. 2015. PMID: 27159596 Review.
-
Evaluation of immunodiagnostic tests for human gnathostomiasis using different antigen preparations of Gnathostoma spinigerum larvae against IgE, IgM, IgG, IgG1-4 and IgG1 patterns of post-treated patients.Trop Med Int Health. 2021 Dec;26(12):1634-1644. doi: 10.1111/tmi.13679. Epub 2021 Sep 21. Trop Med Int Health. 2021. PMID: 34510662 Free PMC article.
-
Cross-Reactivity Pattern of Asian and American Human Gnathostomiasis in Western Blot Assays Using Crude Antigens Prepared from Gnathostoma spinigerum and Gnathostoma binucleatum Third-Stage Larvae.Am J Trop Med Hyg. 2016 Aug 3;95(2):413-6. doi: 10.4269/ajtmh.16-0176. Epub 2016 Jun 20. Am J Trop Med Hyg. 2016. PMID: 27325806 Free PMC article.
-
Molecular identification and genetic diversity of Gnathostoma spinigerum larvae in freshwater fishes in southern Lao PDR, Cambodia, and Myanmar.Parasitol Res. 2019 May;118(5):1465-1472. doi: 10.1007/s00436-019-06292-z. Epub 2019 Mar 25. Parasitol Res. 2019. PMID: 30911911
-
Gnathostomiasis: An Emerging Infection of Raw Fish Consumers in Gnathostoma Nematode-Endemic and Nonendemic Countries.J Travel Med. 2015 Sep-Oct;22(5):318-24. doi: 10.1111/jtm.12212. Epub 2015 May 22. J Travel Med. 2015. PMID: 25997919 Review.
References
-
- Anantaphruti M.T., Koga M., Nuamtanong S., Nintasen R. Esophageal deformation of Gnathostoma spinigerum in ivermectin-treated rats, and anthelminthic efficacy. Helminthologia. 2010;47:88–93. doi: 10.2478/s11687-010-0014-y. - DOI
Publication types
LinkOut - more resources
Full Text Sources